Zobrazeno 61 - 70
of 277
pro vyhledávání: ''
Autor:
Tomoyuki Fujita, Junjiro Kobayashi, Kunihiro Nishimura, Takuma Sato, Yoshihiro Murata, Kyoichi Wada, Yoshihiro Miyamoto, Takuya Watanabe, Haruki Sunami, Hatsue Ishibashi-Ueda, Yu Kataoka, Hiroki Hata, Masanobu Yanase, Takeshi Nakatani, Yumiko Hori, Seiko Nakajima, Norihide Fukushima, Kensuke Kuroda, Osamu Seguchi, Norihiro Okada, Eriko Hisamatsu
Publikováno v:
Transplantation
Background The influence of preexisting donor-transmitted atherosclerosis (DA) on cardiac allograft vasculopathy (CAV) development remains unclear. Methods We performed 3-dimensional intravascular ultrasound (3D-IVUS) analysis in 42 heart transplanta
Autor:
I. Jolanda M. de Vries, Rutger H. T. Koornstra, Gerty Schreibelt, Harm Westdorp, Carl G. Figdor, Kalijn F. Bol, Cornelis J. A. Punt, Erik H.J.G. Aarntzen, Winald R. Gerritsen, Steve Boudewijns, Jeroen H A Creemers
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Journal of Immunotherapy (1997), 39, 241-8
Journal of immunotherapy (Hagerstown, Md., 39(6), 241-248. Lippincott Williams and Wilkins
Journal of Immunotherapy (1997), 39, 6, pp. 241-8
Journal of Immunotherapy (1997), 39, 241-8
Journal of immunotherapy (Hagerstown, Md., 39(6), 241-248. Lippincott Williams and Wilkins
Journal of Immunotherapy (1997), 39, 6, pp. 241-8
Contains fulltext : 172741.pdf (Publisher’s version ) (Open Access) The purpose of this study was to determine the toxicity profile of dendritic cell (DC) vaccination in stage III and IV melanoma patients, and to evaluate whether there is a correla
Publikováno v:
Anti-Cancer Drugs
To observe drug-induced hepatotoxicity by long-term gefitinib administration in the treatment of non-small-cell lung cancer. The data of 101 patients with locally advanced or metastatic non-small-cell lung cancer, for which gefitinib had been used or
Autor:
Linda de Munck, Jacques C. de Graaf, Frank G A Jansman, Sabine Siesling, James E. Boers, Johan M. van Rooijen, Guusje M. Teeuwen
Publikováno v:
Anti-cancer drugs, 27(2), 127-132. Lippincott Williams and Wilkins
Anti-Cancer Drugs, 27(2), 127-32. LIPPINCOTT WILLIAMS & WILKINS
Anti-Cancer Drugs, 27(2), 127-32. LIPPINCOTT WILLIAMS & WILKINS
The addition of trastuzumab to chemotherapy in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) prolongs overall survival (OS) in clinical trials. However, treatment patterns and survival in daily practice are u
Autor:
David R. Thomas, Eva Havrdova, Douglas L. Arnold, Miroslav Stojanovic, Jeffrey A. Cohen, Michael Panzara, Stephen Lake, Alasdair Coles, D Alastair S Compston, Howard L. Weiner, Krzysztof Selmaj, Hans-Peter Hartung, Gavin Giovannoni, Elizabeth Fisher, David Margolin, Vesna V. Brinar
Publikováno v:
Neurology
Neurology, 87(14), 1464-1472. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 87(14), 1464-1472. LIPPINCOTT WILLIAMS & WILKINS
Objective: To describe detailed MRI results from 2 head-to-head phase III trials, Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis Study I (CARE-MS I; NCT00530348) and Study II (CARE-MS II; NCT00548405), of alemtuzumab vs subcutaneo
Autor:
Anil Can, Clemens M F Dirven, Rose Du, Ruben Dammers, Edward R. Laws, Whitney W. Woodmansee, Timothy R. Smith, Bradley A. Gross
Publikováno v:
Neurosurgery, 79(2), 253-263. Lippincott Williams & Wilkins (Wolters Kluwer)
Background The prevalence of hypothalamic-pituitary dysfunction after aneurysmal subarachnoid hemorrhage has not been precisely determined, and conflicting results have been reported in the literature. Objective To perform a systematic review and met
Autor:
Charalambos Deliveliotis, Dimitra Molyva, Dionisios Mitropoulos, Athanasios Papatsoris, C. Kalofonos, Meletios A. Dimopoulos, Stavros D. Peroukidis, Ioannis Adamakis, Kimon Tzannis, Konstantinos Stravodimos, Vassiliki Pissanidou, Nikolaos Pistamaltzian, Georgia Milaki, Athanasios Dellis, Vasilis Karavasilis, Ioannis M. Varkarakis, Nikos Androulakis, Constantinos Constantinides, Ilias Athanasiadis, Iraklis Mitsogiannis, Aristotelis Bamias, Charalambos Andreadis
Publikováno v:
Anti-Cancer Drugs
Relapsed urothelial cancer represents an unmet medical need. Vinflunine is a third-generation antimicrotubuline inhibitor and is currently the only approved drug for second-line treatment across the European Union. We conducted a retrospective analys
Autor:
Lutgarde Thijs, Lucas S. Aparicio, Ichiro Tsuji, Paula E. Cuffaro, Yutaka Imai, Jan A. Staessen, George S. Stergiou, José Boggia, José Alfie, Lotte Jacobs, Gabriel Waisman, Masahiro Kikuya, Jessica Barochiner, Takayoshi Ohkubo, Augustine N. Odili, Kyoko Nomura, Kei Asayama
Publikováno v:
Hypertension, 66(4), 865-873. LIPPINCOTT WILLIAMS & WILKINS
To generate outcome-driven thresholds for home blood pressure (BP) in the elderly, we analyzed 375 octogenarians (60.3% women; 83.0 years [mean]) enrolled in the International Database on home BP in relation to cardiovascular outcome. Over 5.5 years
Autor:
Zimet, C N, Held, M L
Publikováno v:
Journal of Medical Education. Feb1975, Vol. 50 Issue 2, p157-66. 92p.
Autor:
Marian Christoph, Neidert, Nicolai, Maldaner, Martin Nikolaus, Stienen, Michel, Roethlisberger, Daniel W, Zumofen, Donato, D'Alonzo, Serge, Marbacher, Rodolfo, Maduri, Isabel Charlotte, Hostettler, Bawarjan, Schatlo, Michel M, Schneider, Martin A, Seule, Daniel, Schöni, Johannes, Goldberg, Christian, Fung, Marta, Arrighi, Daniele, Valsecchi, Philippe, Bijlenga, Karl, Schaller, Oliver, Bozinov, Luca, Regli, Jan-Karl, Burkhardt, Christian, Mondadori
BACKGROUND The Barrow Neurological Institute (BNI) scale is a novel quantitative scale measuring maximal subarachnoid hemorrhage (SAH) thickness to predict delayed cerebral ischemia (DCI). This scale could replace the Fisher score, which was traditio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f005b3fd36aec5310785b317afd7850